Agenda

Return

C. 55

To:	Board of Supervisors
From:	William Walker, M.D., Health Services Director
Date:	May 12, 2015

Contra

Costa

County

Subject:

Thermo Fisher Scientific, Inc. Purchase Order Amendment

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 05/12/2015

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Mary N. Piepho, District III Supervisor
Karen Mitchoff, District IV Supervisor

ABSENT:

Federal D. Glover, District V Supervisor

Contact:	Anna Roth, 370-5101
cc:	T Scott C Rucker Crystal Grayson

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: May 12, 2015
David Twa,

BY:	, Deputy

RECOMMENDATION(S):

Approve and authorize the Purchasing Agent, on behalf of the Health Services Department, to execute an amendment to Purchase Order #F51317 with Thermo Fisher Scientific, Inc., to add $125,000 for a new total of $575,000 for various clinical and pathology laboratory reagents, small equipment, supplies and test kits for Contra Costa Regional Medical Center (CCRMC) and the Contra Costa Health Centers, with no change in original term of May 2, 2014 through April 30, 2015.

FISCAL IMPACT:

100% funding is included in the Hospital Enterprise Fund I Budget.

BACKGROUND:

Our usage went over the approved Purchase Order amount due to the increase in cost of reagents and supplies. Our patient population has also increased, which has caused an increase in the ordering of these items. These reagents, small equipment, supplies, test kits, controls, etc. are used for patient’s specimen testing and are specific to the analyzer used for testing. Among the tests conducted are those for diabetes, kidney function, liver, hepatitis, iron deficiency, cardiovascular disease, cancer, and many others.

CONSEQUENCE OF NEGATIVE ACTION:

If this Purchase Order is not approved the laboratory will not be able to perform patient testing. This will impact patient safety and care.

CHILDREN'S IMPACT STATEMENT:

No impact.